Myocarditis: What’s New in 2025

Myocarditis: What’s New in 2025   Guest: Leslie T. Cooper Jr., M.D. Host: Kyle W. Klarich, M.D.   After this episode of Mayo Clinic’s cardiovascular podcast series “Interviews With the Experts,” the listener will be able to identify the novel 2024 ACC Expert Care Decision Pathway (ECDP) 4-stage classifications of myocarditis. Hear today’s expert discuss pivotal tests in the diagnosis of myocarditis, such as cardiac magnetic resonance (CMR) imaging and endomyocardial biopsy (EMB) are considered. Finally, learn more about the indications for genetic testing for myocarditis in your patients.   Topics Discussed: What percentage of adult patients with myocarditis presenting as heart failure with reduced ejection fraction or ventricular arrhythmias have a pathogenic or likely pathogenic cardiomyopathic gene variant? Which of the following are criteria to consider endomyocardial biopsy in the setting of acute myocarditis? Identify Stage B myocarditis based on clinical presentation and testing.   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App:The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.